Transcrocetinate disodium
98%
- Product Code: 103011
CAS:
591230-99-8
| Molecular Weight: | 372.37 g./mol | Molecular Formula: | C₂₀H₂₂Na₂O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Transcrocetinate disodium is primarily used in medical and pharmaceutical research due to its potential therapeutic properties. It has been studied for its ability to enhance oxygen delivery to tissues, making it a candidate for treating conditions like stroke, traumatic brain injury, and other ischemia-related disorders. Additionally, it has shown promise in improving the efficacy of certain cancer treatments by increasing oxygenation in tumor tissues, which can enhance the effects of radiation therapy. Its role in reducing inflammation and oxidative stress further supports its potential application in neurodegenerative diseases and other chronic conditions. Ongoing research continues to explore its broader clinical uses and safety profile.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Brown To Reddish Brown Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | €300.75 |
+
-
|
| 0.010 | 10-20 days | €474.88 |
+
-
|
Transcrocetinate disodium
Transcrocetinate disodium is primarily used in medical and pharmaceutical research due to its potential therapeutic properties. It has been studied for its ability to enhance oxygen delivery to tissues, making it a candidate for treating conditions like stroke, traumatic brain injury, and other ischemia-related disorders. Additionally, it has shown promise in improving the efficacy of certain cancer treatments by increasing oxygenation in tumor tissues, which can enhance the effects of radiation therapy. Its role in reducing inflammation and oxidative stress further supports its potential application in neurodegenerative diseases and other chronic conditions. Ongoing research continues to explore its broader clinical uses and safety profile.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :